PFE Jan 2023 35.000 call
| Previous Close | 15.35 |
| Open | 14.02 |
| Bid | 13.60 |
| Ask | 13.75 |
| Strike | 35.00 |
| Expire Date | 2023-01-20 |
| Day's Range | 13.65 - 14.05 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 11.03k |
- Reuters
Researchers test mRNA technology for universal flu vaccine
An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday. The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer with BioNTech, and by Moderna. It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.
- Motley Fool
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
Much of that debt of gratitude for being able to return to normalcy is owed to the pharmaceutical behemoth Pfizer (NYSE: PFE). Let's dive into Pfizer's fundamentals and valuation to see if we can address this question. Since its founding in 1849, Pfizer has grown into a gargantuan business.
- Zacks
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
